ECLYPS: Multicenter trial of FDG-PET/CT to detect residual nodal disease in locally advanced head-and-neck squamous cell carcinoma (LAHNSCC) after chemoradiotherapy (CRT).

Tim Van den Wyngaert,Nils Helsen,Laurens Carp,Remco de Bree,Michel J. Martens,Carl Van Laer,Isabel Hutsebaut,Philip R. Debruyne,Annelies Maes,Joost van Dinther,Sabine Meersschout,Laurence Goethals,Hilde Verstraete,Kristof Deben,Sara Hakim,Pol Specenier,Olivier Lenssen,Otto S. Hoekstra,Danielle Van den Weyngaert,Sigrid Stroobants

ECLYPS: Multicenter trial of FDG-PET/CT to detect residual nodal disease in locally advanced head-and-neck squamous cell carcinoma (LAHNSCC) after chemoradiotherapy (CRT).

2016

6021Background: FDG-PET/CT surveillance after CRT in LAHNSCC results in non-inferior overall survival (OS) compared to routine neck dissection (ND) (Mehanna H, ASCO 2015). However, optimal imaging ...

Keywords:

Multicenter trial
Radiology
Head and neck squamous-cell carcinoma
PET-CT
Chemoradiotherapy
Pathology
Medicine
fdg pet ct
overall survival
nodal disease
Neck dissection
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations